These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7341521)

  • 1. Biological potency and chromatographic properties of [aspartoyl3]-secretin, [beta-Asp3]-secretin, and secretin (4-27). Products of intramolecular reactions in secretin.
    Voskamp D; Beyerman HC
    Int J Pept Protein Res; 1981 Sep; 18(3):284-8. PubMed ID: 7341521
    [No Abstract]   [Full Text] [Related]  

  • 2. Analogues and fragments of secretin.
    König W; Bickel M; Karch K; Teetz V; Uhmann R
    Peptides; 1984; 5(2):189-93. PubMed ID: 6473152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biological and immunochemical properties of analogues of secretin and vasoactive intestinal peptide (VIP): the vasectrins.
    Beyerman HC; Buijen van Weelderen AW; Chang TM; Chey WY; Grossman MI; Kranenburg P; Scratcherd T; Solomon TE; Voskamp D
    Life Sci; 1981 Aug; 29(9):895-902. PubMed ID: 7300581
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydrokinetic activity of secretion and secretin analogues, modified in the N-terminal sequence, and of vasoactive intestinal peptide in the dog pancreas.
    Lehnert P; Forell MM; Jaeger E; Moroder L; Wünsch E
    Digestion; 1981; 22(2):85-8. PubMed ID: 7274610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation peptides of secretin after storage in acid and neutral aqueous solutions.
    Tsuda T; Uchiyama M; Sato T; Yoshino H; Tsuchiya Y; Ishikawa S; Ohmae M; Watanabe S; Miyake Y
    J Pharm Sci; 1990 Jan; 79(1):53-6. PubMed ID: 2313577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side products in the synthesis of secretin.
    Wünsch E; Bovermann G; Göhring W; Peters B; Scharf R
    Biol Chem Hoppe Seyler; 1990 Mar; 371(3):223-9. PubMed ID: 2340106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon antagonists. Synthesis and inhibitory properties of Asp3-containing glucagon analogs.
    Andreu D; Merrifield RB
    Eur J Biochem; 1987 May; 164(3):585-90. PubMed ID: 3032623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism and kinetics of secretion degradation in aqueous solutions.
    Tsuda T; Uchiyama M; Sato T; Yoshino H; Tsuchiya Y; Ishikawa S; Ohmae M; Watanabe S; Miyake Y
    J Pharm Sci; 1990 Mar; 79(3):223-7. PubMed ID: 2338631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of biologically active porcine secretin and [ITyr10] porcine secretin.
    Kofod H
    Int J Pept Protein Res; 1991 Mar; 37(3):185-90. PubMed ID: 1651289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical and biological properties of porcine secretin and secretin analogues modified in positions 3 and 4.
    König W; Geiger R; Wissmann H; Bickel M; Obermeier R; Teetz W; Uhmann R
    Gastroenterology; 1977 Apr; 72(4 Pt.2):797-800. PubMed ID: 838238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different actions of secretin and Gly-extended secretin predict secretin receptor subtypes.
    Solomon TE; Varga G; Zeng N; Wu SV; Walsh JH; Reeve JR
    Am J Physiol Gastrointest Liver Physiol; 2001 Jan; 280(1):G88-94. PubMed ID: 11123201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The solid phase synthesis of porcine secretin with full biological activity.
    Hemmasi B; Bayer E
    Int J Pept Protein Res; 1977 Jan; 9(1):63-70. PubMed ID: 838532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of protected secretin 16-27 on a Merrifield resin. Examination of ammonolysis conditions for preparing carboxamide terminal protected peptides suitable for fragment condensation.
    Wright DE; Agarwal NS; Hruby VJ
    Int J Pept Protein Res; 1980 Mar; 15(3):271-8. PubMed ID: 7380611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gastrointestinal hormones].
    Okuda K
    Horumon To Rinsho; 1973 Nov; 21(11):1143-50. PubMed ID: 4592120
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on secretin. III. Purification of porcine secretin by high performance liquid chromatography and comparison of the product with synthetic secretin.
    Uchiyama M; Sato T; Yoshino H; Tsuchiya Y; Tsuda T; Kawashima H; Nakatani T
    Chem Pharm Bull (Tokyo); 1985 May; 33(5):2006-10. PubMed ID: 4053224
    [No Abstract]   [Full Text] [Related]  

  • 16. Improvements in the synthesis of secretin by the repetitive excess mixed anhydride (REMA) method.
    Beyerman HC; Kranenburg P; Schaaper WM; Voskamp D
    Int J Pept Protein Res; 1981 Sep; 18(3):276-83. PubMed ID: 7341520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and some pharmacological properties of the 23-peptide 15-lysine-secretin-(5--27). Special role of the residue in position 15 in biological activity of the vasoactive intestinal polypeptide.
    Bodansky M; Natarajan S; Gardner JD; Makhlouf GM; Said SI
    J Med Chem; 1978 Nov; 21(11):1171-3. PubMed ID: 214557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of vasoactive intestinal peptide and its stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments.
    Waelbroeck M; Robberecht P; De Neef P; Chatelain P; Christophe J
    Biochim Biophys Acta; 1981 Nov; 678(1):83-90. PubMed ID: 6272875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of phenolic group containing analogues of porcine secretin and their immunological properties.
    Yanaihara N; Kubota M; Sakagami M; Sato H; Mochizuki T
    J Med Chem; 1977 May; 20(5):648-55. PubMed ID: 853504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proform of secretin with high secretin-like bioactivity.
    Gafvelin G; Carlquist M; Mutt V
    FEBS Lett; 1985 May; 184(2):347-52. PubMed ID: 3996590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.